Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Aug 5, 2020, before the open
10-Q filed Aug 10, 2020, 41 days after period end · 0001171843-20-005789
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $23.31M | $29.58M | $31.52M | $18.96M |
| Net Income | -$1.58M | -$247.00K | -$1.46M | -$381.00K |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.04 |
| -$0.01 |
| -$0.04 |
| -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
